Johnson & Johnson COVID-19 Vaccine Less Effective Against Delta Variant With Only 33% Efficacy Rate

Medicine & Technology Jul 21, 2021

A study claims that one dose of the Johnson & Johnson COVID-19 vaccine is less effective against the Indian Delta variant compared to other vaccines like Pfizer and Moderna.

AHA Notes that Risks of Blood Clots After Receiving COVID-19 Vaccines “Extremely Low”

May 01, 2021

The American Heart Association (AHA) released new guidance stressing that developing blood clots after taking a COVID-19 vaccine is "extremely low."

COVID-19 Johnson & Johnson Vaccine: Blood Clots No Impact to Efficacy, Will Jabs Work for Mutant Variants?

Apr 29, 2021

Experts discuss the rare cases of blood clots linked to the COVID-19 Johnson & Johnson vaccine.

CDC Recommends Resumption of Use of Jonhnson & Johnson Vaccine After Investigating Rare Blood Clotting Incidents

Apr 23, 2021

The CDC has recommended resumption of the use of the Johnson & Johnson COVID-19 vaccine in the United States after the stoppage of immunizations to investigate reports of rare blood clots.

FDA Grants Emergency Use Authorization to Johnson & Johnson COVID-19 Vaccine

Feb 27, 2021

The FDA approved Johnson & Johnson’s COVID-19 vaccine for emergency use. The new vaccine is the first single-dose shot for coronavirus protection.

Is J&J’s COVID-19 Vaccine Safe and Effective? Here's What FDA Says

Feb 25, 2021

Johnson & Johnson's single-dose vaccine is 66.1% effective in reducing virus disease and shows evidence of stopping the transmission of the virus.

Johnson & Johnson COVID-19 Vaccine: How Effective Is It?

Feb 01, 2021

Johnson & Johnson's COVID-19 vaccine is effective with only a single dose, but questions swirl regarding decreased safety against one viral variant.